Deutsche Bank upgraded Allscripts-Misys Healthcare (NASDAQ: MDRX) from Hold to Buy and raises their price target to $24.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE